PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
466868-0	1979	Measurement of clofibric acid (CPIB) metabolites in plasma of patients on clofibrate therapy.	Clofibrate	74-84	cystatin B	Homo sapiens	31-35	
6595991-1	1984	The pharmacokinetics of clofibric acid (CPIB, the active metabolite of clofibrate) has been studied in two species of non-human primate after administration by two routes at three dose levels.	Clofibrate	71-81	cystatin B	Homo sapiens	40-44	
466868-2	1979	The metabolites of clofibric acid [CPIB;2-(chlorophenoxy)-2-methylpropionic acid] are present in the plasma of patients on clofibrate therapy.	Clofibrate	123-133	cystatin B	Homo sapiens	35-39	
578436-2	1977	Results warrant further investigation of the potential therapeutic application of ML 1024 in humans based on its superiority to the well-known antilipemic clofibrate (CPIB).	Clofibrate	155-165	cystatin B	Homo sapiens	167-171	
1149779-3	1975	Clofibrate (as the acid, p-chlorophenoxyisobutyric acid, CPIB) was quantified by thin-layer and gas-liquid chromatography.	Clofibrate	0-10	cystatin B	Homo sapiens	57-61	
1149779-4	1975	In patients taking clofibrate only, mean plasma CPIB concentration before the morning dose of clofibrate was 123 mug/ml.	Clofibrate	19-29	cystatin B	Homo sapiens	48-52	
1149779-4	1975	In patients taking clofibrate only, mean plasma CPIB concentration before the morning dose of clofibrate was 123 mug/ml.	Clofibrate	94-104	cystatin B	Homo sapiens	48-52